Fusetec 3D is the first commercial anatomical soft tissue reproduction company in Australia. Fusetec is a new company embracing the latest technology available making Research & Development the foundation of our corporate culture. Fusetec collaborates with highly respected medical professionals, institutions and universities, continuously evolving additive manufacturing technology to improve medical device applications. Fusetec along with our partnership arrangements will continue to develop, new materials and IP to better simulate the human anatomy. Fusetec believes that within the next decade it may be possible to 3D print human organs for transplant and every aspect of our learning will get us one step closer to this quantum leap forward in healthcare.
Mark Roe Chief Executive Officer
While performing his duties as CEO of a national group of companies, Mark was contacted by a Medical Professional whom stated, "there has been an accident and I need to source a 3D printed skull insert, can you help?" Although he said “no”, that request was the catalyst to diversify his career, he broadened his knowledge and identified an important gap in the medical industry where he could provide assistance; within a few months, Mark was touring the US studying 3D advanced technology for medical applications.
After a successful manufacturing career, winning hundreds of awards both domestically and abroad, Mark was excited by the challenge and opportunity to make a difference in the Additive Manufacturing industry. He was confident he would be able to adapt his skills and embrace the rapidly evolving technology.
Mark heads up our Research & Development team, collaborating with several universities as well as overseeing the day to day functions of Fusetec 3D.
John Budgen Chief Operating Officer
John is an experienced business manager of twenty-five years, responsible for multiple manufacturing sites across Australia servicing many ASX listed companies. John has much digital experience, couple that with a strong sales background and a healthy passion for technology, he compliments Mark’s entrepreneurial drive.
Combined they are a formidable team with aspirations to improve medical training from the old school approach of ‘watch one, do one, teach one.’ To training with exacting repeatable standards without risk to patients and where mistakes are somewhat encouraged as apart of learning.